Cleared Traditional

PathVisionXL (K183142) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K183142 · Faxitron Bioptics, LLC · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2019
Decision
121d
Days
Class 2
Risk

K183142 is an FDA 510(k) clearance for the PathVisionXL. Classified as Cabinet, X-ray System (product code MWP), Class II - Special Controls.

Submitted by Faxitron Bioptics, LLC (Tucson, US). The FDA issued a Cleared decision on March 14, 2019 after a review of 121 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1680 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Faxitron Bioptics, LLC devices

Submission Details

510(k) Number K183142 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 13, 2018
Decision Date March 14, 2019
Days to Decision 121 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
14d slower than avg
Panel avg: 107d · This submission: 121d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MWP Cabinet, X-ray System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1680
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MWP Cabinet, X-ray System

All 26
Devices cleared under the same product code (MWP) and FDA review panel - the closest regulatory comparables to K183142.
TrueView 200 Pro-US Specimen Radiography System (TrueView 200 Pro-US)
K230136 · Compai Healthcare (Suzhou) Co.,Ltd · Apr 2023
TrueView Core 100Pro-US Core Specimen Radiography System (TrueView Core 100Pro-US)
K230140 · Compai Healthcare (Suzhou) Co.,Ltd · Apr 2023
Solas OR
K213691 · Cirdan Imaging, Ltd. · Dec 2021
Kubtec Mozart Supra (XPERT 84) Radiography System
K210955 · Kub Technologies, Inc. · Sep 2021
Kubtec Mozart (XPERT42)
K210956 · Kub Technologies, Inc. · Aug 2021
Kubec Xpert 80 Radiography System
K210957 · Kub Technologies, Inc. · Aug 2021